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The effect of anthralin and its oxidation products danthrone 
and anthralin-dimer on the production of 5-lipoxygenase 
products (5-HETE, leukotriene B4, w-oxidized LTB4) by 
Ca-ionophore A 23187-stimulated human neutrophil s has 
been studied in vitro. Anthralin exhibited dose-dependent 
inhibitory activity showing 50% inhibition at 7 fLM with 
107 neutrophils. Inhibitory effects strongly depended upon 
cell densities and m aximal inhibition occurred at low cell 
concentrations, whereas inhibitory rates of anthralin were 
low at high cell densities. 
Inhibition of leukotriene production persisted after 
washing of anthralin-trea ted neutrophils. Also, with in-
A nthralin is a w idel y uscd top ica l antipsori atic rcmcdy 11] . Dcspitc numero us clinica l and cxpe rimental in-vestigations thc way that anthralin affects c1caring of psoriatic Icsions is still no t full y unders tood. In th e past, it has bccn sho wn that anthralin inhibits 
g lyco lyt ic cn zymcs [2,3]. Othcr studies have shown that undcr 
ce rtain circum sta nces anthralin m ay have antipro lifcra tive as well 
as antircsp irato ry activity [4-7]. Rcccnt work in o ur laboratory 
revea led that anthralin inhibits va rious functiona l rcsponses of 
hum an neutrophi ls [8J. 
Bccausc clinical trials to successfu ll y appl y anth ra lin to in flam-
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Abbrcviations: 
BSA: bovine sc rum albumin 
w-COO H-LTB,, : 20-tarboxy-L TB" 
5(S), 12(S),di HETE: 5(S),12(S)-dih ydroxy-6-cis-8-trans-l0-trans-
14-cis-cicosate traenoic acid 
12-cpi-6-trans-L TB.: 5(5), 12(S)-dihydroxy-6,8, 1 O(a ll trans)-14-cis-
cicosatctracnoic acid 
HETE: hydroxycicosatetracnoic acid 
HPLC: high-perform ance liquid chroma tography 
ICsu: half ma xi mum inhibition concentration 
L TB,,: 5(5), 12(R)-di hydroxy-6-cis-8-trans- 1 O-trans-14-cis-
eicosatctracno ic acid 
w-O H-L TB,,: 20-hydroxy-LTB" 
PBS: phosphate-buffered sa line 
PCB, : prostaglandin B2 
PMN : polymorphonuclcar leukocytes 
RP: rcverscd phase 
6-trans-L TB,,: 5(S), 12(H)-dihydroxy-6, 8, 1 0(3 /1 trans) -14-cis-
cicosa tctraclloic acid 
creasing amounts of arachidonic acid as substrate only slight 
changes of inhibitory activity were detected, indica ting a 
non competitive way of action. In addition to the inhjbition 
of leukotriene-production, the format ion of w-OH-L TB4 
from LTR, as well as w-COOH-LTB4 from w-oH-LTB4 
was inhibited with IC so (ha lf maximum inhi bition concen-
tration) ncar 4.4 fLM and 2.2 fLM , respectively. In contrast 
to anthralin, both metabolites-danthrone as well as an-
thralin-dimer-did not show any effect on leukotriene pro-
du ction and w-oxidation even at high concentrations (up 
to 70 fLM and 44 fLM , respectively) . ) II/ ves/ Derma/of 87:624-
629, 1986 
m atory skin discascs other than pso rias is have mostl y fa iled, it 
appears reasolllble to suppose th at the way anthralin works in 
skin may be re lated to spccific fea turcs of the pso riati c tissue 
chan ges. 
In psoriasis, elevated levels of frce arachidonic acid as well as 
12-HETE have recentl y been detectcd [9]. In additio n, 5-lipox-
ygcnase produ cts were found in thc di seased cpidermi s [10] and 
LTB,,-likc m atc rial was dcm o nstratcd in sca les [11] from patients 
w ith psoriasis. 
Alth ough the o ri g in of th ese po tcnt infl ammatory m ediato rs is 
speculati vc at thc mom ent, thcoretica ll y 12-lipoxygenase prod-
ucts could o rig inate from ep id erm al cclls whereas 5-lipoxygenase 
products could mainly derive from infiltrate cells, possibly neu-
trophils. 
In a reccnt stud y, Bedord et all1 2J have shown that anthra li n 
cffectively rcd uccs the production of 12-HETE from mouse epi-
dermal ho mogenates w ithout affectin g synthesis of cyclooxy-
genase produ cts. In the prcsent stud y the cffects of anthralin as 
well as of its mctabolites danth rone and dimeric anthralin on the 
releasc of 5-lipoxygena se produ cts (leukotricnes and 5-HETE) 
from Ca-ionophorc-stimulated hum an neutrophils were inves-
tigated. O ur resu lts suggcst that part of the anti psoriati c activity 
of anthralin m ay be related to inhibition oflcukotricne productio n 
in infiltratin g neutrop hil s. 
MATERIALS AND METHODS 
Calcium ionopho re A 23187, arachidonic acid (99% pure), pros-
tag landin B 2 (PGB2), and 1,8-dih yd roxy-dianthron (dan throne) 
were purchased from Sigma C hemic, Munich , F.n.G. Standard 
LTB" was a generous gift of Dr. J. Robeh, M erck Frosst, Canada. 
Standard 5-HETE was a genero us gift of Dr. Bartmann, Hoechst 
AG, Fra nkfurt . Standard w-OH-L TB" as well as w-COOH-L TB. 
and 5,6 DiHETEs were from Paesel GmbH, Frankfurt; stand ard 
6-t rans-LTB" and 12-epi-6-trans-L TB" were a generous g ift of 
Dr. G. Losehen, C hemi e Gri.inentha l GmbH, Stolberg (F.R.G.) 
o r have been iso lated from Ca-ionophore- stilllulated hum an neu-
trophils by publi shcd m ethod s [1 3]. L TB", w-OH-LTB,,, and 5-
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HET E were furth cr charac teri zed by inhercnt chemo tactic acti vity 
and UV spcctra. 1, 8-Dih ydroxyanthronc (anthralin , d ithrano l) 
was a g ift fro m Bayc r AG, Levcrkusen, F.R. G ., and was frce of 
impurities as assessed by hi gh-perfo rm ance liquid chro n1Jtog-
ra ph y (HPLC) analys is. It was d isso lved in acetonc (10 mg/ml) 
and dilu tcd in phos phatc-buffercd sa linc (PBS), pH 7.2, contain-
ing 0. 1 % (w/v) bov ine serum albumin (S ig m a) just befo re ex-
pe riments were perfo rm ed. 
D imeri c anthralin (1,8, 'I ' ,8' -tetrah yd ro xydianthrone) w as sy n-
th esized acco rding to the mcthod of Allterhoff and Scherff [141 . 
Fin a l purifica tion was assessed by preparati ve thin-l ayer chro-
m atograph y. Identity and puri ty have been proved by melting 
point, I R- and ' H-nuclea r magnetic reso nance spectra. Di111 eri c 
anthralin has been d isso lved in acetone (5 111 g/ml ) and di luted as 
described fo r anthra lin. 
Cell Preparation Po lym o rpho nucl ea r leukocytes (PMN) fr0 111 
health y dono rs were isolated as previously described 11 51 usin g 
a s li ght m odifica tion of the m eth od of Henson 11 61. Because of 
va ri able am ounts of contam inatin g m ononuclea r cells as well as 
pl a te lets, crude PMN preparations (containing > 90% PMN) were 
furth er purified by Fi co ll-H ypaque centrifu gatio n. T he sediment 
was was hed tw ice in Ca + .. -free PBS, containin g 1 % (w/v) bovine 
se rum albumin (BS A), pH 7.2, and sto red at 4°C until ex peri -
ments started . Usin g this techniqu e fin al cell preparations con-
tained mo re than 98% PMN (>93% neut rophils) w ith a viability 
g rea ter th an 97% as assessed by trypan blue exclusion. T he m ain 
contaminants o f these preparations were eosinophils (2-7%). Platelet 
con tamin ation did not exceed 2% of the g ranulocy tes. 
Incubation Procedures Polymo rphonuclea r leukocytes (107 
cell s/assay) were preincubated w ith anthra-deri vatives in PBS, 
pH 7.2, containing 128 mM N aC l, 8. 1 m M N a2HPO ." 1.5 
lTlM KH 2P0 4, 2.7 111M KC I, 0. 1 % (wlv) g lu cose, and 0. 1 % 
(w/v) BSA, fo r 15 min at 37"C, fo llowed by a 5-min in cubation 
with 1 ° J.L M arachido nic acid (prepared by eva po ration o f m eth-
ano li c stock solution and subsequ ent solubiliza ti on w ith 50 J.L I 0.1 
M N aHCOJ and PBS containing 0. 1% BS A). T herea fter CaCl2 
(0.6 mM) as well as Ca I I - ionophore A-23187 (10 J.LM ) were added . 
In c ubation was ca rri ed o ut in a shaker bath fo r 10 min and then 
stopped by coolin g in an ice bath . Aftcr centri fuga tion super-
nata nts werc co llected and 100 ng PGB2 as well as th c radi cal 
scavcnger 4-hydroxy-2,2,6,6-tetramcth ylpiperidin ooxy frcc rad-
ica l (2 J.Lg) [1 7 1 wcre added and storcd under argon at -70°C 
un ~il they were analyzed by rcversed- phase (RP)-HPLC. 
In ex pcrim ents , w hcre LTB4 mctabo lism was in vcs ti gated , hu-
m a n PMN (107 cell s/3 m l) wcre incubated w ith 200 ng L TB., for 
30 min at 37°C in th e presence o r absencc o f anthralin . Prein-
cuba tion with anthralin as well as terminatio n of cnzy m atic re-
actio n was perform cd as describcd. 
Reversed-Phase High-Performance Liquid Chromatogra-
phy Fo r cxtractio n o fleuk otriencs octadecyl(C 18)-RP ca rtridges 
(Sep Pak, Waters) wcre used, whi ch werc first washed with meth-
ano l and wa tcr, respecti vel y, acco rdin g to thc m anu fac turcr 's 
instructions. 
Aftcr appl yin g thc cell supern atant (pH 7.2) to th e RP- 18-
ca r t rid ge (3x) and waslung w ith water, adsorbed leukotriencs 
wer e eluted w ith methan ol (usuall y 3 m l). Rccove ry fo r all lcu-
ko t r ienes as w ell as 5-HET E and the internal stand ard PGB2 was 
fo und to bc better than 80% . 
M cthanoli c solutions o f leukotriencs were eva po rated undcr 
argo n and the residue solubilized in 400 J.Ll of mcth anoIl0. 12% 
amm onium acctate-buffcr, pH 5.4 (50 :50) . 
I-li gh-pcrfo rman cc liquid chrom atog raph y was perfo rmcd w ith 
a 4.6 X 250 mm Altex Ultraspherc O DS 5-J.L1ll co lumn , attached 
to a Spectra Ph ys ics SP 8 700 pump and a Kratos Spectrofl ow 
783 UV detecto r. 
T h c so lvcnt systcm was a gradicnt of m ethano l (A) and 0. 12% 
amm onium acetate, pI-! 5.4 (B ). Thc column was eluted w ith th e 
fo llo wing protocol: time 0 min : 50% A, 50% B; tim e 6 l1lin : 60% 
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A, 40% B; time 12 min : 60% A, 40% B; tim e 28 min: 70% A, 
30% B; tim e 50 min: 70% A; 30% B; timc 52 min: 100% A, timc 
65 min: 100% A. A fl ow rate of 1.0 ml / min at 50°C w as m ai n-
taincd and th e efflu cnt was m on ito rcd at 270 nm (leuk otricnes) 
o r 237 nl11 (monohydroxy acids). 
Pca k areas were integ ratcd w ith a Spectra Ph ysics SP 4270 
computin g integrator to quanti fy leukotrienes by relation to ex-
tern al standards of authenti c sa mpl es. The rccovcry of th c in te r-
national standard PGB2 was used to co rrect fo r losses durin g 
sa 111 pie preparati on. M olar abso rption coeffi cicnts (M - , CI11 - ') of 
28,650 fo r PGB2 and 50,000 fo r the lcuko tricnes at 270 nm and 
29,500 fo r the 111 0no hydroxy acids at 237 nl11 [1 71 were uscd. 
Statistics T hc Wilcoxon rank-sum tcs t fo r pa ircd and un paircd 
sa m ples w as uscd to assess sta ti stica l signi fica nce. 
RES ULTS 
Arachidonate Metabolism b y Ionophore-Stimulated Neu-
trophils When nelltrophils were in cubated w ith arachidonic 
acid (10 J.LM) as w ell as C a-ionophorc (10 J.L M) fo r 10 min at 37°C 
fo ll owed by tc rminati on of the reaction b y coo lin g in an icc bath, 
a typical I-IPLC pro file was obtained (Fig '1). 
T he gradient sys tem used in our H PLC analyses allowed si-
mul ta neous asscss mcnt of (v-ox idized Ieukotriencs, leukotriencs, 
and H ET ES. As shown in Fig '1, typica l elution times were 6.3 
min fo r w-COO H L TB~, 9.5 min fo r w-O I-I-L T B." 22.3 min fo r 
trans-L TB." 23.8 min fo r cpi-trans-L T B." 25.5 min fo r L T B4, 
and 43.0 min fo r 5-HETE. 
In this system wc arc un able to dist in guish betwecn L TB~ and 
thc intcraction products 5(S), 12(S)-diHETE; howcver further 
analys is of thc L TB~ pea k by a diffe rent H P LC solvent system 
[tctrahydro furan:m eth anol:ammonium acetate (0. 1 %, w lv , pH 
5.4) (25 :30: 45) ] de mo nstrated negli gible (5%) conta min ation of 
5,'1 2-diHETE . T his is evidencc that by our iso latio n and purifi-
ca tion procedurc platclet contaminatio n of the PMN preparations 
is nca rl y absent. 
Effects of Anthralin Pretreatment on Leukotriene Produc-
tion Pretreatment of ncutrop hils w ith anthralin (30 J.LM) and 
subsequcnt ac ti va ti on of ~)MN-5-lipoxygen ase by Ca-io no pho re 
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Figure 1. Reversed phase H PLC chromatograms of arachidonic acid 
Ill ctaboliti cs synthesized by calcium ionophore A 23 187 (10 /-LM)-stilllu-
Iated humanncutrophils (107 cells in 3 ml) ill the absence (I), and prescnce 
(J I) of 30 /-L M anthralin . Thc cffl uent was contilluously Ill onitored at 270 
Illll (0-36 min fo r I , 0-32 min fo r II) and 237 nm (36-45 min fo r I , 32-45 
fo r II). Pea k identifica tion: 1, w-COO I-I -LTll, : 2, w-OH-LTB~: 3, PGB2 (internal standard); 4, 6-trans-LTB,; 5, 12-cpi-6-trans-LTB,: 6, LTB.: 7. 
5.6-DiHETE; 8, 15-HETE; 9, 12-HETE: 10, 5-HETE. A typical ex p('r-










Figure 2. Dose-dependent inhibition of ionophore-stilTlulated L T pro-
duction of hulTl an PMN (107 cell s in 3 ml) by anthra lin. Mean amounts 
of L TB" (-x-), tota l L TB" (= sum of L TB", w-OH-LTB., and w-COOH-
L TB., -9-), w-OH-L TB" (--A--), w-COOH-LTB" (--0--), as well as 
5-HETE (--e--) of6 experiments were expressed in percent of the vehicle 
control, corrected for recovery by recovery of the PGB2 control. Typical 
amounts isolated fro m stimulated neut rophils were 83.2 ng LTB., 11 2,6 
ng w-OH-L TB., and 30.4 ng w-COO H-L TB" (= 100% control). Note 
increased amounts (104,2 ng) of LTB" at low (2-5 /L M) anthra lin con-
centrations and lower ICsu for production of w-COOH-L TB. and w-OH-
L TB,. Signifi cantl y enh anced 'amounts or L TB" arc indicated by the as-
terisks (p < 0.05). Bars, SO, 
in the presence of arachido ni c acid results in ne rl y complete 
absence of all 5-lipoxygenase-products ofL TB4, trans-LTB4, epi-
trans-L TR" and 5-HETE, as well as both w-ox idation produ cts 
ofLTB4' w-OH-LTB4 and w-COOH - LTB" (Figs 1, 2) . 
To excl ude a direct chemical reac tion of anthralin w ith these 
a rachidonic acid m etabolites, supern atants of io nophore- s timu-
lated n eutrophils (containin g all 5-lipoxygenase products m en-
tioned above) were incubated with anthralin (20 J.L M) for 20 min , 
After HPLC ana lys is no s i gnifi ~ant loss of these 5-lipoxygenase 
produ cts could be de tec ted , !ndica tin g apsen ce of direct effects of 
anthralin on the production of leukotrienes ' (data not shown) , 
A dose-respo nse study revealed an inhi b ition of the 5-lipoxy-
genase-product formation within a narrow concentration range 
of 1- 10 /-LM anthra lin (Fi g 2), Comparison of the half m aximum 
inhibition con centration (ICso) of different 5-lipoxygenase pro d-
ucts revealed simila r IC so for trans-L TB4, epi-trans-L TB4 (data 
not shown) , and 5-HETE, Leukotriene B4 alo ne shows signifi-
ca ntl y increased yie lds at low anthralin concen tratiq ns (Fig 2), 
w hereas dose res po nses of w-OH-L TB4 and w-COOH-L TB" in 
comparison with 5-H ETE are shi fted to lower anthralin concen-
trations. 
Total L TB" (the sum of LTB" plus w-OH-LTB4 plus w-COOH-
LTB4) pro du ced b y P MN resulted in the sa m e IC so as that seen 
for 5-HETE (Fig 2), 
Effect of Anthralin on Cd-Oxidation ofLTB4 Anthralin pre-
treatm ent o f h uman neutrophils res ulted not onl y in diminished 
formation of L TB4 and 5-HETE, but also in d ecreased amounts 
of w-OH-L TB4 and w-COOH-L TB4 (Fig 2). Sin ce this find in g 
could be the result of decreased L TB4 synthesis as well as de-
creased w-oxidation , neutrophils were in cubated w ith L TB" in 
th e presence or absen ce of different con centration s of anthralin. 
Typica l HPLC chromatograms of these experimen ts are shown 
in Fig 3. This fig ure revea ls that anthralin inhibits formation of 
w-COOH-LTB4 as well as w-OH-LTB". Dose-response studies 
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Figure 3. Reversed phase HPLC chromatograms of LTB4 metaboli tes 
synthesized by human neut rophils (107 cell s/3 ml) in the absence (control) 
and presence of 1.4 or 7.1 /L M anthralin. Peak identifica tion : 1, w-COOH-
LTB.; 2, w-OH-L TB.; 3, internal standard PGB2; 4, L TB., Note increased 
amounts of w-OH-LTB. (73.2 ng compared with 46,2 ng in the control) 
as well as decreased amounts of w-COOH-L TB. (68.4 ng cpmpared with 
88.2 ng in the control) after trea tment w ith 1.4 /L M anthralin . One typ ical 
experiment is shown. 
shown in Fig 4 m ake it possible to ca lculate the IC so for formation 
of w-OH-L TB4 by inhibitio il of total w-OH-LTB4' w hich is the 
sum of w-OH-LTB4 plus w-COOH-LTB4. 
It is n o teworthy that IC so fo r the formatio n of w-COOH-LTB4 
is lower (2,2 /-LM ) co mpared with the formation of w-OH-LTB4 
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Figure 4. Dose-dependent inhibition of L TR, metabolism to w-OH-
L TB4 and w-COOH-OTB., Typical yields ofleukotrienes after treatment 
of PMN with LTB. were 54.2 ng w-O H-LTB. and 74,6 ng w-COOH-
L TB, (= 100% control). Neutrophils (107 cells/3 ml) were incubated for 
30 min at 37"C with 200 ng LTB4 in the presence or absence of anthralin. 
Mean amounts of w-OH-LTB. (-x-) , tota l LTB. (sum of w-O H-LTB. 
and w-COOH-L TB" , --A--) , as well as w-COOH-L TB. (-0-) of 6 ex-
p.eriments were expressed in percent of the vehicle control (0.1 % acetone) 
corrected fei r recovery by recovery of the internal standard PGB2 . Note 
increased yields of w-O H-LTB. at low « 1 /LM) anthralin concentrations 
and shifted dose responses of w-COO H-L TB. and tota l w-OH-L TB •. 
Signifi cantly enhanced amounts of w-OH-L TB. are indicated by the as-
terisk (p < 0.05), The 0 value is expressed on abscissa. Bars, SO , 
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Table I. Effect of Washing on Anthralin (74 J.LM)-Dependent 
Inhibition of Leukotriene Production by Human 
Polymorphonuclear Leukocy tes (PMN) (3 x 107/3 ml) 
Product % Control" % Controlb 
w-OH-LTB., 54 .8 ± 12.7 21 .2 ± 6. 1 
trans-LTB. 24.4 ± 8.3 14.4 ± 3.4 
epi-trans-L T il. 26.3 ± 10. 1 16.1 ± 4.9 
LTB, 78.9 ± 16.3 28.9 ± 5.8 
5-H ETE 39. 1 ± 7.2 18.5 ± 4.4 
"PMN were washed 2 rilll es w ith PBS. hpMN were /l o t washed . Data arc the 
result or3 experiments :t SD. 
Effect of Washing of Anthralin-Treated Cells on Leuko-
triene Production In an additional series of ex periments neu-
trophils were thoroughly washed after preincubation with an-
thralin . As shown in Table I, leukotriene production is inhibited 
after washing of the cell s, however w ith increased IC so. 
Effect of Anthralin at Different Cell Densities In these ex-
periments different neutrophil densities (2 x 106 to 30 x 106 
, PMN/ ml were preincubated at constant anthralin concentrations 
(7, 29, and 74 J.LM) for a constant leng th of time (20 min) at 37°C. 
As s hown in Fi g 5, the inhibitory activity of an thralin on PMN 
lipoxygenase pathways not on ly depends upon the anthralin con-
centration but also upon the cell density used . When 4 x 107 
PMN per assay were used, an IC su nea r 74 J.LM w as found; how-
ever with 107 PMN the IC so decreased to 7 J.LM. Usin g as low as 
3 X 106 PMN per assay, an IC so of 0.9 J.LM was observed (data 
not s hown) . 
Effect of Dan throne and Dimeric Anthralin on Leukotriene 
Production Because anthralin easily deco mposes to both me-
tabolites (danthrone and dimeric anthralin) , w e studied the influ-
ence of these components on leukotriene synthesis. With both 
co m.pounds no significant inhibitory effect was seen at concen-
trations up to 70 J.LM for danthrone or up to 44 J.LM for dimeric 
anthralin (Table II) . 
Effect of Different Substrate Concentrations on Anthralin-
Dependent Inhibition of Leukotriene Production The ef-
fect of increasing ara chidonic acid concentration s on L TB4 as well 
as 5 - HETE production at different anthralin concentrations is 
shown in Table III. Only when large amounts of arachidonic acid 
were used did leukotriene production increase. 
10 20 3 0 40 50 
Neutrophi ls x 10 . 6 
Figure 5. Effect of anthtalin at different cell densities . Neutrophils were 
preincubated with 7, 29, and 74 J.LM anthralin at different cell densities 
and stimulated thereafter with 10 J.LM arachidonic acid. Data (mean amounts 
of tota l formed L TB,) are expressed in percent of the vehicle (0. 1 % 
acetone) control. The results of 4 experiments ± SD (bars) arc showll . 
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Table II . Influence of Danthrone and Dimeric Anthralin on 
Leukotriene and 5-HETE Prod ucti on by Poly m orphonuclear 
Leukocytes (PMN) (107/ ml) 
Product % Control' % Controlb 
w-OH-LTB, 93 ± II 96 ± 12 
tralls-LTB, 95 ± 9 91 ± 8 
epi-trans-L TB, 98 ± 5 99 ± 13 
LTB, 104 ± 12 96 ± 16 
5-HETE 103 ± 9 103 ± 15 
<l pMN were prcin cub:Hcd w ith 70 jLM d:ulthroll c. IIPMN were prcincub:u cd w ith 
44 J.LM dimeric anthralin . Da ta sho w results of 3 ex periments ± SO. 
DISCUSSION 
Human neutrophils contain enzy m e systems capable of genera ting 
leukotrienes and 5-HETE from exogenous arachidonic acid [1 3) . 
The main products released by ncutrophils after stimulation with 
Ca-ionophore A-23187 are potent chemotaxins like LTB, [1 8] 
and its metabolite w-OH-L TB" (1 9), as well as 2 nOl1 chemotactic 
iso mers of L TB" , 6-trans-L TB4 and 12-epi-6-trans-L TB", and in 
addition 5-HETE [20). 
In the present study we investiga ted the influence of anthralin 
on the production of several 5-lipoxygenase products of Ca-ion-
ophore-stimulated human neutrophils. 
The results demonstrate that the clini call y ac tive anti psoriati c 
dru g anthralin-in contrast to its meta bolites danthrone and di-
m eric anthralin-is a potent inhibitor ofleukotriene.and 5-HETE 
production by hum an neutrophils (Figs 1, 2; Table II). The IC so 
for 5-HETE and leukotriene production is shown to be near 7.5 
J.L M when 107 PMN w ere used. This is nea rl y 5-fold lower than 
the IC so found for 12-HETE production of crud e epidermal ho-
mogenates (12). 
Because earlier investigations [17 ,21) as well as additional spec-
troscopic and biologic studies carried out in o ur laboratory re-
vealed that it is possible to characterize most of the 5-lipoxygenase 
products released from neutrophils by RP-HPLC techniques, our 
studies were performed without the use of radioactive labeled 
arachidonic acid. 
U sin g this procedure, no interference in retention time was 
seen with the drugs used in this stud y. 
The m echanism(s) by w hich anthralin affects the production 
of leukotrienes, is not clear at the present time. However so me 
of the findin gs reported here as w ell as previously published ob-
servations (8) may help to identify particular aspects of the in 
vivo action of anthralin. It is noteworthy that the lCso for the 
production of5-HETE as well as tota l L TB, and both non chem o-
tactic iso m ers of L TB", whi ch are formed nonenzymatica lly by 
hyd rolysis of LT A., is nea rl y identica l. Therefore it is reasonable 
Table III. Effect of Substrate Concentration on the Inhibition 
of Ca-lonophore-Stil11ulated 5-HETE and T o tal L TB" 
Production by Anthralin-Treated N eutrophils (107/3 ml) ' 
Percent Inhibition 
Anthralin 
Arachidonic Acid (J.LM ) 
(J.LM ) 1. 5 15 150 
5-HETE 20 104 ± 12 102 ± 12 82 ± 8 
production 40 103 ± 15 94 ± 18 93 ± 10 
LTB, 20 98 ± 14 91 ± 9 76 ± to' 
productionb 40 95 ± 13 96 ± 15 78 ± 7' 
II Results o f six ex periments ± SI) arc shown. 
' By means the sum of L T8,. w-OH-L TB,. and w-COOH-L T8, produced by 
human neutro phils. 
'Significa ntly lower OJ < 0.05) than co ntrol. 
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to suggest that anthralin inhibits th e 5-lipoxygenase by interfer-
ence with the formation of the intermediate 5-HPETE, w hich is 
a precursor of LT A4. Thus anthralin may possibly fun ction as a 
radical trapping antioxidant. 
A prio ri , one could expect such a phenoli c agent to be a rela-
tively nonspecifi c inhibito r of all lipoxygenases, since these en-
zy matic reactions proceed via radica l mechanisms. It should be 
no ted, however, th at the standard antioxidant nordih ydroguaiar-
etic acid shows di fferent inhibito ry ac tivities in platelet 12-lipox-
ygenase and PMN-5-lipoxygenase (unpublished) . T herefore it is 
possible that differential sensitivity of these lipoxygenases may 
exist toward antioxidants. Altern atively it may be possible that 
anthralin inhibits the activation of5-lipoxygenase via enzyme act-
ivation by Ca + + . 5-Lipoxygenase requires Ca + + for activation in 
vi tro; however, in contras t to this, 12-lipoxygenase does not [22]. 
An unexpected result is the potent inhibitory effect of anthralin 
on the catabolism of L TB4 to w-OH-L T B4 and w-C O O H-L TB4 . 
This L T B4 oxidation seems to be of higher sensitivity to anthralin 
treatment as compared with the synthesis ofLT B4 • The profound 
inhibitory effect of anthralin seen in the w-oxidation of L TB4 
leads to a decrease of w-oxidation products of anthralin at con-
centrations w hich only slightly affect the synthesis of LTB4. As 
a consequence of this inhibitory activity on the catabolism LT B4 
accumulates (Fig 4). 
It is interesting to note th at high concentrations of arachidoni c 
acid (>20 JLM) also lead to a decreased synthesis of w-C O O H-
L TB4 and partly w-O H-LT B4- as first mentioned by Salari et 
al [23] . 
To further evaluate the inhibitory role of anth ralin on L TB4 
catabolism , we performed separate inhibition experiments with 
anthralin using LTB4 and w-OH-LTB4' respectively , as sub-
strates. In this system the ICso for the fo rm ation of w-COO H-
L T B4 (Figs 3, 4) was lowest compared to formation of w-O H-
LTB4. 
Inhibition of L TB4-w-oxidation is possibly linked with inhi-
bition of LT B4-20-hydroxylase, w hich has recently been isolated 
and characterized in human neutrophils [24,25] . T he synthesizing 
capacity of this enzy me results fro m a cytochrome P-450 oxy-
genation system [26]. To our knowledge- apart from carbon 
monoxide [27] and long-chain terminal acetylenic fatty acids [28]-
anth ralin is the fi rst agent that is kn own to inhibit w-oxidation 
of L TB4 in vitro. Looking at the conditions w hich are present in 
vivo, inhibition ofLTB4 catabolism by human neutrophil-L TB4-
20-hydroxylase, however, may no t playa significant ro le because 
anthralin concentra tions measured in epidermis of psorias is after 
treatment are reported to be 10- to lOO-fold higher th an IC so of 
w-oxidation [29,30] . Under these conditions production of leu-
kotrienes appea rs to be to tally blocked (Fig 2). In view of these 
observations it is interesting to speculate that anthralin may also 
inhibit other P-450 systems, which are seen in various tissues, 
and are able to catalyze w-oxidation of pros taglandins and long-
chain fa tty acids [31-33], and could result in accumulation of these 
compounds. 
T he anth ralin-induced inhibi tion of leukotriene synthesis was 
reduced in neutrophils preincubated with anthralin followed by 
washing (Table I) . In addition to this the inhibitory effects of 
anth ralin are only slightl y influenced by increased substrate con-
centrations (Table 1II) . This indi cates th at inhibition of the leu-
kotriene generatin g system mainl y works in the noncompetitive 
way. 
It should be noted that anthralin-treated neutrophils-even after 
washing- show an intensive brownish colo r, which appears to 
depend on a chemical reaction of anthralin with cellular (mem-
brane) components as has been shown ea rlier [8]. This, however, 
did not result in cytotoxicity, since in all experim ents performed 
with anth ralin , cyto toxic effects were not responsible fo r the effects 
described here. T his was evidenced by the absence of any release of 
the cytoplasmaticenzyme lactate dehydrogenase [8]. 
As an important observation we could show that the inhibitory 
effect of anthralin depends not only on the concentration of an-
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thralin used for preincubation but also on the cell density . This 
is in accordance with the hydroph obicity of anthralin . At lowest 
cell densities inhibition ofl eukotriene synthesis was st ronges t (Fig 
5) , w hich gives addi tional evidence for the irreversible type of 
inhibition by anthralin . With these results we are able to calculate 
the critical amount of anthralin necessa ry to produce half maxi-
mum leukotriene synthesis per neutrophil. T his is 1 pg anthralin 
per cell. 
Taken together, the important part of the mode of action of 
anthralin seems to be related to cutaneous inflammati on by in-
hibition of cellular L TB4 production together w ith effects on the 
other cellular functi ons in psorias is. T his may help to explain the 
puzzling fact that therapeutic effi cacy of anthralin is for the most 
part restricted to this skin disease. 
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